Medium-Chain Triglycerides (8:0 and 10:0) Increase Mini-Mental State Examination (MMSE) Score in Frail Elderly Adults in a Randomized Controlled Trial
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in The Journal of Nutrition
- Vol. 150 (9) , 2383-2390
Abstract
Supplementation with medium-chain triglycerides (MCTs) was previously shown to increase muscle function in frail elderly individuals. We aimed to assess effects of MCTs on cognition in such individuals. We enrolled 64 elderly nursing home residents (85.5 ± 6.8 y; 13 men, 51 women; BMI 18.6 ± 2.5 kg/m2) in a 3-mo randomized, controlled, single-blinded, intervention trial. Participants were randomly allocated to 3 groups: the first group received supplemental L-leucine (1.2 g) and cholecalciferol (20 μg) enriched with 6 g/d of MCTs (LD + MCT group) as a positive control, the second group received 6 g/d of MCTs (MCT group) as the test nutrient, and the third group received 6 g/d of long-chain triglycerides (LCT group) as a negative control. Cognition (secondary outcome) was monitored 4 times: baseline, 1.5 and 3 mo after initiation of the intervention (intervention), and 1.5 mo after termination of the intervention (postintervention follow-up). Cognition scores were assessed by a linear mixed model (intention-to-treat analysis). MCT supplementation increased the Mini-Mental State Examination (MMSE) score by 3.5 points at the 3-mo intervention from baseline (P < 0.001) [intention-to-treat adjusted means: baseline 17.5 points (95% CI: 14.9, 20.2), 3-mo intervention 21.0 points (18.3, 23.7)], whereas LCT supplementation decreased the MMSE score by -0.7 points [baseline 17.0 points (95% CI: 14.4, 19.6), 3-mo intervention 16.3 points (13.6, 18.9)]. At the 3-mo intervention, the difference in MMSE score between the MCT (21.0 points) and LCT (16.3 points) groups became significant (P < 0.05). The increase in MMSE score in response to MCTs was 2.1-fold greater at 3 mo than at 1.5 mo and had returned to baseline value at the 4.5-mo postintervention follow-up visit. Supplementation with 6 g MCTs/d may improve the cognition of frail elderly individuals. This trial was registered at umin.ac.jp as UMIN000023302.Keywords
This publication has 22 references indexed in Scilit:
- Medium-chain triglycerides (8:0 and 10:0) are promising nutrients for sarcopenia: a randomized controlled trialThe American Journal of Clinical Nutrition, 2019
- The Role of Ghrelin in Regulating Synaptic Function and Plasticity of Feeding-Associated CircuitsFrontiers in Cellular Neuroscience, 2019
- Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled TrialJournal of Nutritional Science and Vitaminology, 2017
- Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Increase Muscle Strength and Function in Frail Elderly Adults in a Randomized Controlled TrialThe Journal of Nutrition, 2016
- Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot studyClinical Interventions in Aging, 2016
- Review of brief cognitive tests for patients with suspected dementiaInternational Psychogeriatrics, 2014
- Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialNutrition & Metabolism, 2009
- Ghrelin is a growth-hormone-releasing acylated peptide from stomachNature, 1999
- Scales for Mental State and Daily Living Activities for the Elderly: Clinical Behavioral Scales for Assessing Demented PatientsInternational Psychogeriatrics, 1993
- “Mini-mental state”Journal of Psychiatric Research, 1975